Moderna Deferred Taxes increased by 1.6% to $253.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $234.00M to $253.00M. Over 2 years (FY 2023 to FY 2025), Deferred Taxes shows relatively stable performance with a 2.9% CAGR.
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
other_deferred_income_tax_liabilities_net| Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $235.00M | $241.00M | $231.00M | $234.00M | $237.00M | $239.00M | $249.00M | $253.00M |
| QoQ Change | — | +2.6% | -4.1% | +1.3% | +1.3% | +0.8% | +4.2% | +1.6% |
| YoY Change | — | — | -1.7% | — | — | -0.8% | +7.8% | +8.1% |